Polygenic Risk Score May Predict Sudden Death in Some CAD Patients

WEDNESDAY, Sept. 7, 2022 (HealthDay News) -- Being in the top decile for the genome-wide polygenic score for coronary artery disease (GPS_CAD) is associated with an increased risk for sudden and/or arrhythmic death (SAD) among CAD patients without severe systolic dysfunction, according to a study published in the Aug. 30 issue of the Journal of the American College of Cardiology.

Roopinder K. Sandhu, M.D., M.P.H., from the Cedars-Sinai Medical Center in Los Angeles, and colleagues examined whether a GPS_CAD would have utility in SAD risk stratification in 4,698 CAD patients without severe systolic dysfunction. The cohort was dichotomized according to top GPS_CAD decile, as defined by the general population.

The researchers found that participants in the top GPS_CAD decile were at elevated absolute SAD risk (8.0 versus 4.8 percent) and proportional SAD risk (29 versus 16 percent) compared with the rest of the participants during a median follow-up of 8.0 years. The top GPS_CAD decile was associated with SAD after controlling for left ventricular ejection fraction, clinical factors, and electrocardiogram parameters, but it was not associated with non-SAD. The addition of the top GPS_CAD decile to the multivariable model significantly improved continuous and categorical net reclassification indexes but did not improve the C-index.

"These findings in aggregate suggest that the GPS_CAD is a promising method to improve SAD risk stratification in CAD patients who do not currently qualify for an implantable cardioverter-defibrillator, which warrants further study," the authors write.

One author disclosed financial ties to the biopharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)